Stemsation International Stock EBITDA
| STSN Stock | USD 0.01 0.0004 6.78% |
Stemsation International fundamentals help investors to digest information that contributes to Stemsation International's financial success or failures. It also enables traders to predict the movement of Stemsation Pink Sheet. The fundamental analysis module provides a way to measure Stemsation International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stemsation International pink sheet.
Stemsation |
Stemsation International Company EBITDA Analysis
Stemsation International's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Stemsation International reported earnings before interest,tax, depreciation and amortization of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The ebitda for all United States stocks is 100.0% higher than that of the company.
Stemsation EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stemsation International's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Stemsation International could also be used in its relative valuation, which is a method of valuing Stemsation International by comparing valuation metrics of similar companies.Stemsation International is currently under evaluation in ebitda category among its peers.
Stemsation Fundamentals
| Current Valuation | 3.81 M | |||
| Shares Outstanding | 24.76 M | |||
| Price To Sales | 727.92 X | |||
| Net Income | (29.58 K) | |||
| Cash And Equivalents | 178 | |||
| Total Debt | 339.98 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (181) | |||
| Earnings Per Share | (0) X | |||
| Beta | 0.22 | |||
| Market Capitalization | 3.47 M | |||
| Total Asset | 1.92 K | |||
| Z Score | 6.0 | |||
| Net Asset | 1.92 K |
About Stemsation International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stemsation International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stemsation International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stemsation International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Stemsation Pink Sheet
Stemsation International financial ratios help investors to determine whether Stemsation Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemsation with respect to the benefits of owning Stemsation International security.